Pulmonary and systemic circulatory effects and  -adrenergic selectivity of hexoprenaline, salbutamol, oxyfedrine, and isoproterenol.
D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D002396:Catechols / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005263:Femoral Artery; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology*; D011651:Pulmonary Artery; D011652:Pulmonary Circulation / Q000187:drug effects*; D011941:Receptors, Adrenergic; D012039:Regional Blood Flow / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects*
D000605:Amino Alcohols; D002082:Butylamines; D002396:Catechols; D010627:Phenethylamines; D011427:Propiophenones; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D007545:Isoproterenol